Hirsutism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2024-11-27
EMA Authorised: Vaniqa (eflornithine) — Almirall, S.A.
The European Medicines Agency authorised Vaniqa (eflornithine) for the treatment of hirsutism. The marketing authorisation holder is Almiral…